First, Ilaris and now Serelaxin. Seems to be a pattern. Let's hope Secukinimab gets approved, but unfortunately it will be used likely as last line or limited therapy given the potential double injection per dose requirement.
Hey leadership- All those external hires making big bucks for months sitting at home will now need to get the boot- Nice job wasting time and money- I guess it was good all the internal people did NOT get any of the positions.- HA HA mother fuckers!
